Related Experiment Video
Updated: May 27, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Levetiracetam-induced interstitial nephritis in a patient with glioma
Ali Mahta1, Ryan Y Kim, Santosh Kesari
1Department of Neurosciences, Moores Cancer Center, University of California San Diego, 3855 Suite 3336, Health Sciences Drive, La Jolla, California 92093-0819, USA.
Abstract:
A 45-year-old man with a new diagnosis of low grade glioma was started on an escalating dose of levetiracetam (Lev) for seizure management. He gradually developed intractable nausea/vomiting and a high creatinine concentration due to acute renal failure which was attributed to Lev-induced interstitial nephritis. The medication was changed and his renal function rapidly improved to his baseline.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Encephalitis l: Introduction
Antiepileptic Drugs: Glutamate Antagonists
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy
